Related Experiment Videos
Intravenous anesthetics in sepsis
Cheng-Ming Tsao1, Chin-Chen Wu, Jhi-Joung Wang
1Department of Anesthesiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan, ROC.
Summary
Intravenous anesthetics can mitigate sepsis by suppressing harmful inflammatory responses. These drugs reduce pro-inflammatory cytokines, nitric oxide, and neutrophil activity, offering potential benefits in intensive care settings.
Area of Science:
- Pharmacology
- Immunology
- Critical Care Medicine
Background:
- Overactive inflammation drives severe sepsis complications like septic shock and multiple organ failure.
- Understanding modulators of inflammatory pathways is crucial for sepsis management.
Purpose of the Study:
- To review the anti-inflammatory effects of intravenous anesthetics in sepsis.
- To explore how these agents modulate inflammatory cells and cytokine activity.
Main Methods:
- Review of in vitro and in vivo studies on intravenous anesthetics and inflammation.
- Analysis of endotoxin-induced inflammatory responses.
Main Results:
- Intravenous anesthetics generally depress endotoxin-induced pro-inflammatory cytokine activity.
- These agents reduce nitric oxide generation, free radical production, and neutrophil activity.
- Different anesthetics (propofol, ketamine, benzodiazepines, barbiturates) show varying degrees of anti-inflammatory inhibition.
Conclusions:
- Intravenous anesthetics possess promising immunomodulatory properties relevant to sepsis.
- These agents may play a significant role in intensive care for managing sepsis-induced inflammation.